Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Receivables (2016 - 2026)

Phibro Animal Health has reported Change in Receivables over the past 13 years, most recently at -$2.3 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 106.67% year-over-year to -$2.3 million; the TTM value through Dec 2025 reached $15.7 million, down 67.75%, while the annual FY2025 figure was $55.2 million, 536.18% up from the prior year.
  • Change in Receivables for Q4 2025 was -$2.3 million at Phibro Animal Health, up from -$11.4 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $35.0 million in Q4 2024 and troughed at -$22.3 million in Q3 2022.
  • A 5-year average of $4.5 million and a median of $5.5 million in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: plummeted 411.02% in 2022 and later surged 7819.86% in 2024.
  • Year by year, Change in Receivables stood at $2.9 million in 2021, then surged by 154.85% to $7.5 million in 2022, then plummeted by 120.44% to -$1.5 million in 2023, then skyrocketed by 2379.41% to $35.0 million in 2024, then tumbled by 106.67% to -$2.3 million in 2025.
  • Business Quant data shows Change in Receivables for PAHC at -$2.3 million in Q4 2025, -$11.4 million in Q3 2025, and $26.0 million in Q2 2025.